Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,453 | 291 | 99.8% |
| Education | $10.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $867.29 | 70 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $797.75 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $562.93 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $475.67 | 38 | $0 (2020) |
| Astellas Pharma US Inc | $291.89 | 20 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $278.09 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $253.15 | 13 | $0 (2024) |
| Amgen Inc. | $167.91 | 14 | $0 (2020) |
| Novo Nordisk Inc | $162.06 | 9 | $0 (2020) |
| Merck Sharp & Dohme LLC | $154.73 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $322.22 | 15 | AstraZeneca Pharmaceuticals LP ($102.94) |
| 2023 | $188.78 | 9 | Novartis Pharmaceuticals Corporation ($85.80) |
| 2022 | $89.68 | 5 | Novartis Pharmaceuticals Corporation ($35.50) |
| 2021 | $115.29 | 8 | PFIZER INC. ($115.29) |
| 2020 | $788.65 | 49 | AstraZeneca Pharmaceuticals LP ($180.96) |
| 2019 | $883.68 | 58 | PFIZER INC. ($232.35) |
| 2018 | $1,066 | 76 | AstraZeneca Pharmaceuticals LP ($218.04) |
| 2017 | $1,010 | 73 | Janssen Pharmaceuticals, Inc ($241.99) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Immunology | ||||||
| 07/19/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 04/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Cardiovascular | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Cardiovascular | ||||||
| 05/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Cardiovascular | ||||||
| 10/25/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 397 | 515 | $146,730 | $41,738 |
| 2022 | 9 | 603 | 1,018 | $224,017 | $89,728 |
| 2021 | 9 | 936 | 1,689 | $310,825 | $163,774 |
| 2020 | 30 | 1,362 | 2,448 | $243,379 | $115,898 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 157 | $50,083 | $14,778 | 29.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 157 | 162 | $52,974 | $14,723 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 179 | $39,559 | $11,216 | 28.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 17 | 17 | $4,114 | $1,021 | 24.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 149 | 454 | $78,628 | $35,217 | 44.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 124 | 137 | $45,358 | $20,513 | 45.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 170 | 177 | $39,779 | $14,293 | 35.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 144 | $31,824 | $8,202 | 25.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 34 | $13,328 | $5,729 | 43.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 27 | 27 | $4,644 | $2,643 | 56.9% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 20 | 20 | $4,320 | $1,231 | 28.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,000 | $1,176 | 29.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $2,136 | $723.54 | 33.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 287 | 891 | $126,522 | $68,508 | 54.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 245 | 278 | $76,728 | $42,140 | 54.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 235 | 267 | $38,982 | $21,232 | 54.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 32 | 113 | $44,296 | $18,964 | 42.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 53 | 55 | $9,460 | $5,271 | 55.7% |
| 99235 | Hospital observation or inpatient care moderate severity, 50 minutes per day' | Facility | 2021 | 28 | 29 | $7,221 | $3,356 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 22 | $3,973 | $2,301 | 57.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 23 | 23 | $2,576 | $1,393 | 54.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 11 | $1,067 | $609.40 | 57.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 91 | 288 | $52,688 | $23,555 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 119 | 119 | $24,157 | $13,116 | 54.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 165 | 312 | $31,305 | $12,489 | 39.9% |
About Dr. David Shupe, D.O
Dr. David Shupe, D.O is a Family Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1306192372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Shupe, D.O has received a total of $4,463 in payments from pharmaceutical and medical device companies, with $322.22 received in 2024. These payments were reported across 293 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,453).
As a Medicare-enrolled provider, Shupe has provided services to 3,298 Medicare beneficiaries, totaling 5,670 services with total Medicare billing of $411,139. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Jacksonville, FL
- Active Since 07/27/2012
- Last Updated 01/10/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306192372
Products in Payments
- FARXIGA (Drug) $687.35
- ELIQUIS (Drug) $518.94
- XARELTO (Drug) $481.85
- MYRBETRIQ (Drug) $291.89
- ENTRESTO (Drug) $234.47
- LYRICA (Drug) $185.81
- BREO (Drug) $164.70
- TRELEGY ELLIPTA (Drug) $142.97
- Ozempic (Drug) $115.58
- JARDIANCE (Drug) $106.38
- JANUVIA (Drug) $101.28
- CHANTIX (Drug) $94.39
- SYMBICORT (Drug) $86.51
- Prolia (Biological) $84.78
- ANORO (Drug) $84.44
- TRADJENTA (Drug) $82.55
- INVOKANA (Drug) $75.06
- Vascepa (Drug) $72.79
- TRULICITY (Drug) $70.07
- COLOGUARD (Device) $61.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jacksonville
Colin Lacroix, M.d, M.D
Family Medicine — Payments: $94,208
Dr. Sarfaraz Dhanji, Md, MD
Family Medicine — Payments: $48,705
Dr. Kim Barbel-Johnson, D.o, D.O
Family Medicine — Payments: $46,143
Victor Micolucci, M.d, M.D
Family Medicine — Payments: $39,554
Herman Downey, Md, MD
Family Medicine — Payments: $32,440
William Schwartz, D.o, D.O
Family Medicine — Payments: $32,173